Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation-Reference-Cited by-同舟云学术

Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation

Published:2018-05-16 Issue:1 Volume:136 Page:167-169
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Jain Payal,Surrey Lea F.,Straka Joshua,Luo Minjie,Lin Fumin,Harding Brian,Resnick Adam C.,Storm Phillip B.,Buccoliero Anna Maria,Santi Mariarita,Li Marilyn M.,Waanders Angela J.

Funder

National Institutes of Health

Pediatric Low Grade Astrocytoma Foundation

Voices Against Brain Cancer

The Children's Brain Tumor Foundation

Rally Foundation

Thea's Star of Hope

Lauren Loose foundation

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s00401-018-1864-5/fulltext.html

Reference12 articles.

1. Bandopadhayay P, Ramkissoon LA et al (2016) MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 48:273–282. https://doi.org/10.1038/ng.3500

2. Hirose T, Scheithauer BW (1998) Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma. Acta Neuropathol 95:649–654

3. Holbrook JD, Parker JS et al (2011) Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. J Transl Med 9:119. https://doi.org/10.1186/1479-5876-9-119

4. Huse JT, Snuderl M et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133:417–429. https://doi.org/10.1007/s00401-016-1639-9

5. Jain P, Fierst TM et al (2017) CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles. Oncogene 36:6348–6358. https://doi.org/10.1038/onc.2017.276

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and morphologic characterization of intraductal tubulopapillary neoplasms of pancreas with novel potentially targetable fusions;Human Pathology;2024-08

2. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions;Nature Reviews Clinical Oncology;2024-02-29

3. FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways;Clinical and Translational Medicine;2023-05

4. Novel FGFR2::ZCCHC24 Fusion in Dysembryoplastic Neuroepithelial Tumor;Journal of Neuropathology & Experimental Neurology;2022-09-26

5. The landscape of common genetic drivers and DNA methylation in low‐grade (epilepsy‐associated) neuroepithelial tumors: A review;Neuropathology;2022-07-17